Treat COVID-19 Patients With Regadenoson
Clinical trial NCT04606069 · COMPLETED
Trial details
- NCT number
- NCT04606069
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2023-04-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.